Melatonin is an endogenous hormone that regulates sleep patterns. It is available in varying formulations and dosages and is marketed as a natural substance that can alleviate insomnia. Recent news reports indicate that melatonin has been administered without appropriate authorization in daycare settings. Even though lethal outcomes have not been solely attributed to exogenous melatonin overdose, it has been relevant to select police and postmortem investigations.
INTRODUCTION
Melatonin (N-acetyl-5-methoxytryptamine) is a hormone produced by the pineal gland in response to decreased light conditions. Its primary purpose is to help regulate the sleep cycle by promoting normal circadian rhythms (1) . Synthetic forms of melatonin are marketed as natural sleep aids and are readily available over-the-counter in various formulations including capsules, tablets, gummies, creams, and sprays (2) . The drug is rapidly absorbed and undergoes extensive metabolism by cytochrome P450 1A2 (CYP1A2) to major (6-OH-melatonin) and minor (desmethylmelatonin) metabolites. These metabolites are then excreted in urine as their sulfate and glucuronide conjugates ( Figure 1 
) (3).
Due to its amphiphilic properties, melatonin readily crosses the blood-brain barrier and enters the cerebral spinal fluid (4) . Its half-life is between 30 and 120 minutes, depending upon dosage and route of administration (5) . Endogenous concentrations fluctuate depending upon the amount of either natural or artificial light experienced by the individual, but typically peak at 2.0 ng/mL (6) . In one study examining melatonin pharmacokinetic parameters in children with autism spectrum disorders, endogenous concentrations in nine subjects ranged up to 0.31 ng/mL (7) . Different doses and dosing regimens are often required taking into account factors such as the sleep behavior to be modified and the age of the individual. Most, however, are designed and used to elevate blood concentrations up to twenty times normal (8) . Furthermore, the LD50, the dose that is lethal to 50% of subjects, could not be established in mice (9) . As such, melatonin is considered safe across a wide range of ages when taken according to manufacturer or medical recommendations.
There are several practical and clinical benefits to synthetic melatonin use. It is inexpensive, accessible without a prescription, and enhances sleep without sedative-hypnotic use. Other touted uses include, but are not limited to, relief of pain associated with fibromyalgia, alleviation of depression, protection against cardiovascular disease, and better outcomes for children with autism (10-13).
It should be recognized, however, that melatonin as a supplement has not been completely evaluated by the Food and Drug Administration (FDA) in any population group. Rigorous clinical trials have not been performed even though there is extensive evidence from animal and human studies that melatonin acts on multiple physiological systems including the reproductive, cardiovascular, and immune systems. The impact to its pharmacokinetic profile, if any, with concomitant use of other medications and supplements by age range has not been investigated (14, 15) . This is especially relevant since CYP1A2 is present at 20-25% of adult levels at ages three to 12 months, and 50-55% of adult levels at ages one to nine years (16) . Reported side effects following administration include daytime drowsiness, dizziness, stomach pain, headache, and depressed mood (17) . Lethal outcomes as a direct consequence of melatonin exposure have Downloaded from www.afpjournal.com by an AFP Journal subscriber This article is for personal use only and may not be shared or distributed in any fashion ORIGINAL ARTICLE not been reported, and in children most instances of accidental overdose do not require in-patient medical evaluation and treatment (18) .
Because melatonin has a reputation for being natural and safe, care providers may be tempted to administer it as a mechanism to induce sleep in children. As a result, pediatric populations can be susceptible to untoward melatonin exposure. Recent media reports demonstrate the reality of this possibility. In Illinois, three employees of a childcare center were accused of administering melatonin gummy bears to toddlers to induce sleep (19) . Another case, from Oregon, resulted in a 21-year prison sentence for a daycare worker. The worker gave seven toddlers and infants in her care melatonin to prevent them from hurting themselves when she would leave to run errands or exercise (20) . A third instance occurred in the summer of 2018 when a child had a pill found in her lunch. It is alleged that the daycare operator had been providing melatonin to the children without parent or guardian authorization for several months. Melatonin was located at the facility (21).
When police or medicolegal investigators must address a suspicion or allegation of melatonin exposure, toxicology testing is often warranted. Positive findings consistent with therapeutic or supratherapeutic concentrations can differentiate between endogenous versus exogenous exposure. In this regard, a quantitative liquid chromatography-tandem mass spectrometry (LC-MS/MS) method designed and validated to determine melatonin concentrations in blood, serum/ plasma, urine, and other fluid specimens is detailed. To underscore the utility of this analytical procedure and to demonstrate a toxicological basis for performing this assay in forensic investigations, two pediatric postmortem cases involving melatonin are discussed.
METHODS

Sample Preparation
The present method requires 0.2 mL of blood, serum/ plasma, or urine. Calibration standards, quality controls, and patient specimens are transferred to test tubes. The internal standard (melatonin-d4) is then added. Samples are buffered with sodium carbonate buffer (pH 9), methyl-t-butyl ether (MTBE) is added prior to rotomixing for 15 minutes followed by centrifugation for ten minutes. The MTBE layer is transferred to test tube, and evaporated to dryness at 55±5℃. Dried extracts are reconstituted with 0.2 mL deionized water:methanol (50:50) and vortexed prior to centrifugation for five minutes. Extracts are transferred to autosampler vials for analysis by LC-MS/ MS.
Method and Instrument Parameters
The calibration line has six calibration points with an analytical measurement range (AMR) of 1.0 -200 ng/ mL. Two levels of quality controls used to monitor the acceptability of sample preparation and method performance were prepared at target concentrations of 3.0 and 150 ng/mL in drug-free human serum. Analysis was performed on a Waters TQD Mass Spectrometer with an ACQUITY Ultra Performance Liquid Chromatograph with a Synergi Fusion-RP 50 x 2.00 mm, 2.5-micron column (part number 00B-4423-B0) and a BetaBasic 18 Drop-In Guard Cartridge, 2.1 x 10 mm, 3-micron pre-column (part number 71503-012101). Analysis was performed with a gradient using 0.1% formic acid in deionized water and 0.1% formic acid in methanol as the mobile phases. The total run time (injection-to-injection) was 1.8 minutes. The transitions monitored for the internal standard and melatonin were 237>178; 237>163, and 233>174; 233>159, respectively (Figure 2) .
RESULTS
Analytical findings from 20 blood samples collected from children ranging in age from three months to nine years were evaluated due to suspicion of melatonin ingestion. Out of these samples, four were from law enforcement, and 16 from death investigators. Demographic information including the gender distribution by case type (police and postmortem) and age are shown in Tables 1 and 2 . Positive findings, greater than the lower limit of quantification (reporting limit) of 1.0 ng/mL, were obtained from both the law en- Figure 3 . Figure 3) A nine-month-old female (37-5/7 WGA) with a birth weight of 7 lbs 8 oz. and a low birth score was found unresponsive after cosleeping with an obese adolescent sibling weighing between 250 and 300 pounds. The mother had a longstanding history of drug abuse, maternal diabetes mellitus, and placenta previa.
CASE REPORTS
First Presented Case (Case 2 in
The decedent was last known alive at 9:00 pm, found the next morning unresponsive at 10:00 am, and pronounced dead at 10:12 am. The caretaker was "partying" the night before and stated, "I was so drunk I do not remember my babies last night". There were additional allegations of neglect including 1) pesticide exposure, 2) dextromethorphan ingestion the afternoon prior to death at approximately 2:00 pm when the decedent drank from her sister's cup, 3) nicotine ingestion from consuming one-half a cigarette, and 4) the finding of a rubber band in the mouth. The caretaker admitted to providing melatonin to the child. The decedent had an unsafe sleeping environment which included cosleeping in a prone position in an adult bed with overstuffed bedding. There was evidence of trauma to the right-side of the scalp, a nasal plume, blanched livor on the right face and abdomen, and right temporalis hemorrhage with focal subscapular and subgaleal hemorrhage. 
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The LC-MS/MS method detailed above was employed on blood and gastric fluid specimens. The melatonin concentrations in these matrices were 13 ng/mL and 1200 ng/mL, respectively. Negative toxicology results were returned for organophosphate pesticides, nicotine, and dextromethorphan. The carboxyhemoglobin and vitreous electrolytes concentrations were within normal limits. The cause and manner of death for this case was ruled undetermined. Figure 3) A 13-month-old male was found nonresponsive in a room shared with his brother. A space heater was located between two playards. Melatonin was found within some of the empty sippy cups and bottles. The decedent was checked on throughout the night but was found unresponsive in the morning. First responders noted the decedent to be extremely warm to the touch. The room temperature was greater than 26.7°C (80°F). Advanced cardiac life support was performed on scene and death was pronounced.
Second Presented Case (Case 6 in
Anatomic and clinical findings include early decomposition with superficial skin slippage, evidence of medical intervention, a large amount of white particulate/granular matter in the stomach, partial thickness burns to the lower extremities with skin slippage, petechiae over the thymus and epicardial surface of the heart, hard impacted stool within the rectum, and aspiration of gastric contents. There was no evidence of blunt or penetrating trauma or skeletal injury.
A blood sample was submitted for toxicological analysis. The described LC-MS/MS method was used and the melatonin reported at 210 ng/mL. Other toxicology results for drugs and alcohol were negative and vitreous electrolyte concentrations were consistent with decomposition. The cause of death was determined to be acute melatonin ingestion and complications of thermal injuries to body, and the manner of death was homicide. One photograph of the scene is shown in Image 1. 
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DISCUSSION
Melatonin is an endogenous hormone produced by the pineal gland to regulate sleep patterns. There are melatonin formulations that are sold for use in children and the substance has been shown to help those that experience autism, true insomnia, or circadian rhythm problems. Severe adverse effects or lethal outcomes as a direct consequence of its use, even in over dosage, have not been reported. Due to these considerations, melatonin is not included in routine toxicology panels designed for postmortem investigations.
One relevant factor to consider, however, is that the pediatric population is vulnerable to mistreatment or abuse. Depending upon circumstances, there may be a temptation for care providers to want infants, toddlers, or school-age children to sleep on demand for extended periods of time. While not always nefarious in nature, this can also indicate or substantiate an environment of neglect. Children, even those that are capable of more advanced communication, may not possess the cognitive skills to recognize a poor care environment or have the emotional maturity to advocate for their physical care.
CONCLUSION
Instances of providing melatonin to induce sleep without the appropriate authorization in a daycare setting have been reported and the presented postmortem cases demonstrate the relevance of melatonin detection and quantification in certain forensic pediatric death investigations. Overall, the presented quantitative LC-MS/MS method can successfully be used to evaluate exposure to exogenous melatonin. The presence of melatonin at a concentration consistent with purposeful administration may speak to surreptitious or untoward use, and for some investigations this will be a critical and valuable finding.
